Clinical Trial Update: Clinical Outcomes in Narcolepsy and Cataplexy: An Evaluation of Reboxetine Treatment (CONCERT) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating reboxetine for narcolepsy with cataplexy completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataplexy
• Excessive Sleepiness
• Narcolepsy

Drugs mentioned

• Reboxetine (Reboxetine)

Snippet

Sponsor: Axsome Therapeutics, Inc. | Conditions: Narcolepsy, Cataplexy Narcolepsy | Phase 2 | Status: COMPLETED | Results posted: 2023-08-24